Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for fanconi anemia.

James M Croop1

  • 1Pediatric Hematology/Oncology, James Whitcomb Riley Hospital for Children, 702 Barnhill Drive, Indianapolis, IN 46202, USA. jcroop@iupui.edu

Current Hematology Reports
|August 7, 2003
PubMed
Summary

Fanconi anemia gene therapy shows promise for bone marrow failure by correcting cellular defects. However, challenges like limited stem cell targets and potential toxicities require a cautious approach for this prototype disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.

Pediatric blood & cancer·2025
Same author

PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation.

Molecular cancer research : MCR·2023
Same author

A phase 1, first-in-child, multicenter study to evaluate the safety and efficacy of the oncolytic herpes virus talimogene laherparepvec in pediatric patients with advanced solid tumors.

Frontiers in pediatrics·2023
Same author

PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.

Blood·2022
Same author

Parents' Insights into Pediatric Oncology Phase I Clinical Trials: Experiences from Their Child's Participation.

Seminars in oncology nursing·2021
Same author

Evidence for BCR/ABL1-positive T-cell acute lymphoblastic leukemia arising in an early lymphoid progenitor cell.

Pediatric blood & cancer·2019

Area of Science:

  • Hematology
  • Genetics
  • Gene Therapy

Background:

  • Fanconi anemia is a hereditary bone marrow failure syndrome.
  • It involves congenital anomalies and cancer predisposition.
  • Patients exhibit hypersensitivity to DNA cross-linking agents.

Purpose of the Study:

  • To evaluate the feasibility of gene transfer for Fanconi anemia.
  • To explore gene therapy as a potential treatment for bone marrow failure.

Main Methods:

  • Correction of laboratory abnormalities by transferring normal Fanconi anemia cDNA into patient cells.
  • Assessment of gene transfer feasibility in human hematopoietic cells.

Main Results:

  • Gene transfer corrected laboratory abnormalities in patient cells.
  • Advances in gene transfer techniques suggest feasibility.
  • Reduced numbers of hematopoietic stem cell targets pose a challenge.

Conclusions:

  • Fanconi anemia serves as a model for gene therapy development.
  • Gene transfer may offer a way to reverse bone marrow failure.
  • Potential toxicities and target cell limitations necessitate caution.

Related Experiment Videos